Package 0074-7094-70

Brand: qulipta

Generic: atogepant
NDC Package Sample

Package Facts

Identity

Package NDC 0074-7094-70
Digits Only 0074709470
Product NDC 0074-7094
Description

4 TABLET in 1 BOTTLE (0074-7094-70)

Marketing

Marketing Status
Marketed Since 2025-12-17
Brand qulipta
Generic atogepant
Sample Package Yes

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "392c0320-ca25-423a-9bc1-d06f6badab07", "openfda": {"nui": ["N0000193917", "N0000193918"], "upc": ["0300747096305", "0300747094301"], "unii": ["7CRV8RR151"], "rxcui": ["2571836", "2571842", "2571844", "2571846", "2571848", "2571850"], "spl_set_id": ["8c8ab8f4-32bd-497a-befa-70c8a51d8d52"], "pharm_class_epc": ["Calcitonin Gene-related Peptide Receptor Antagonist [EPC]"], "pharm_class_moa": ["Calcitonin Gene-related Peptide Receptor Antagonists [MoA]"], "manufacturer_name": ["AbbVie Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "4 TABLET in 1 BOTTLE (0074-7094-04)", "package_ndc": "0074-7094-04", "marketing_start_date": "20211006"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (0074-7094-30)", "package_ndc": "0074-7094-30", "marketing_start_date": "20210930"}, {"sample": true, "description": "4 TABLET in 1 BOTTLE (0074-7094-70)", "package_ndc": "0074-7094-70", "marketing_start_date": "20251217"}], "brand_name": "Qulipta", "product_id": "0074-7094_392c0320-ca25-423a-9bc1-d06f6badab07", "dosage_form": "TABLET", "pharm_class": ["Calcitonin Gene-related Peptide Receptor Antagonist [EPC]", "Calcitonin Gene-related Peptide Receptor Antagonists [MoA]"], "product_ndc": "0074-7094", "generic_name": "Atogepant", "labeler_name": "AbbVie Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Qulipta", "active_ingredients": [{"name": "ATOGEPANT", "strength": "60 mg/1"}], "application_number": "NDA215206", "marketing_category": "NDA", "marketing_start_date": "20210930", "listing_expiration_date": "20271231"}